Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04418011 · ClinicalTrials.gov registry record · NA
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders
A NA study, sponsored by Centre for Addiction and Mental Health.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04418011: Completed NA study, sponsored by Centre for Addiction and Mental Health.
NCT04418011 is a NA study that has completed, run by Centre for Addiction and Mental Health. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04418011, a NA study, has completed, sponsored by Centre for Addiction and Mental Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
In this study, the investigators will be examining the effects of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) on social cognitive impairments in individuals with schizophrenia spectrum disorders. Participants will be chosen by chance to receive either active rTMS stimulation, active iTBS stimulation, sham rTMS, or sham iTBS. The investigators predict that active 10Hz and iTBS stimulation will improve social cognitive impairments compared to sham stimulation. We aim to identify which type of active stimulation is most effective at inducing changes social cognition brain circuitry and secondarily which type of active stimulation is best tolerated and most effective at inducing changes in social cognitive performance.
Primary Outcome
Measured using the empathic accuracy fMRI task
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation
- DEVICE Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation)
- DEVICE Repetitive Transcranial Magnetic Stimulation (Sham)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2023-02-02 |
| Phase | NA |
What the finished NCT04418011 record still lists
NCT04418011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT04418011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04418011 about?
NCT04418011 is a clinical study titled "Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders". In this study, the investigators will be examining the effects of repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) on social cognitive impairments in individuals with schizophrenia spectrum disorders. Participants will be chosen by chance to receive...
What is the current status of trial NCT04418011?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-11-30. Estimated completion is 2023-02-02.
What interventions are being tested in trial NCT04418011?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Repetitive Transcranial Magnetic Stimulation (Intermittent Theta Burst Stimulation) (DEVICE), Repetitive Transcranial Magnetic Stimulation (Sham) (DEVICE).
Who is sponsoring clinical trial NCT04418011?
This trial is sponsored by Centre for Addiction and Mental Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04418011's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI